Target intelligence / Profile preview

Eukaryotic ribosome 28S rRNA sarcin–ricin loop (SRL) (SRL)

Target
SRL
Molecular classification
Ribosomal RNA, RNA motif, Translation machinery component
01

Overview

The Eukaryotic ribosome 28S rRNA sarcin–ricin loop (SRL) is a highly conserved 12-nucleotide RNA motif located within the large (60S) ribosomal subunit that is essential for the elongation phase of protein synthesis (Grela et al., 2019, Int J Mol Sci). It serves as a critical docking and activation site for translational GTPases, including elongation factors eEF1A and eEF2, which are required for aminoacyl-tRNA selection and ribosomal translocation (Shi et al., 2012, J Mol Biol). The SRL is the primary molecular target for potent Ribosome-Inactivating Proteins (RIPs) such as ricin, abrin, and Shiga toxins, which irreversibly damage the loop by removing a specific adenine base (depurination) (Stirpe & Battelli, 2006, Cell Mol Life Sci). Other agents, like the fungal ribotoxin alpha-sarcin, catalyze a specific endonucleolytic cleavage within the loop (Endo & Wool, 1982, J Biol Chem). These modifications prevent the ribosome from interacting with elongation factors, leading to a total cessation of protein synthesis and subsequent cell death. In pharmaceutical development, the SRL is targeted indirectly via immunotoxins, which utilize the catalytic domains of these toxins conjugated to antibodies to selectively destroy cancer cells (Walsh et al., 2013, Toxins).

Other names
Sarcin-ricin loopSRL28S rRNA sarcin-ricin domainAlpha-sarcin loopH95 loop
02

Mechanism of action

Ribosome-inactivating proteins (RIPs) target the SRL to inhibit protein synthesis. Type I and II RIPs, such as ricin and abrin, function as RNA N-glycosidases that specifically depurinate the A4324 residue in the human 28S rRNA (Stirpe & Battelli, 2006, Cell Mol Life Sci). Ribotoxins, such as alpha-sarcin, act as site-specific endonucleases that cleave the phosphodiester bond between G4325 and A4326 (Endo & Wool, 1982, J Biol Chem). Both types of modifications prevent the binding of elongation factors eEF1A and eEF2 to the ribosome, thereby halting the translocation step of translation and inducing apoptosis (Shi et al., 2012, J Mol Biol).

03

Biological functions

Protein synthesisTranslation elongationGTPase activationElongation factor binding
04

Disease associations

InfectionCancerToxicosis
05

Safety considerations

Extreme systemic toxicityVascular leak syndrome (VLS)Immunogenicity of toxin-derived therapeuticsOff-target cytotoxicity in non-malignant cells
06

Interacting drugs

Ricin

5 more in the full profile.

07

Biomarkers

Depurinated 28S rRNA levelsFragmented 28S rRNA (Endo fragment)Inhibition of leucine incorporationCaspase-3 activation

Beyond the preview

Go deeper on Eukaryotic ribosome 28S rRNA sarcin–ricin loop (SRL) (SRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic ribosome 28S rRNA sarcin–ricin loop (SRL) (SRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call